Furthermore, targeting proteins that interact with DDX21 or regulating these interactions such as using WDR5 inhibitors or blocking the DDX21-WDR5-CDC5L interaction offers additional possibilities for CRC treatment. Here, WDR5 is linked to colorectal carcinoma.